Cover Image

Real-Life Therapeutic Concentration Monitoring of Long-Acting Cabotegravir and Rilpivirine: Preliminary Results of an Ongoing Prospective Observational Study in Switzerland

SHCS#879 is an ongoing Switzerland-wide multicenter observational study conducted within the Swiss HIV Cohort Study (SHCS) for the prospective follow-up of people living with HIV (PLWH) receiving long-acting injectable cabotegravir-rilpivirine (LAI-CAB/RPV). All adults under LAI-CAB/RPV and part of...

Full description

Saved in:

Bibliographic Details
Main Authors:	Paul Thoueille (Author), Susana Alves Saldanha (Author), Fabian Schaller (Author), Aline Munting (Author), Matthias Cavassini (Author), Dominique Braun (Author), Huldrych F. Günthard (Author), Katharina Kusejko (Author), Bernard Surial (Author), Hansjakob Furrer (Author), Andri Rauch (Author), Pilar Ustero (Author), Alexandra Calmy (Author), Marcel Stoeckle (Author), Manuel Battegay (Author), Catia Marzolini (Author), Pascal Andre (Author), Monia Guidi (Author), Thierry Buclin (Author), Laurent A. Decosterd (Author), on behalf of the Swiss HIV Cohort Study (Author)
Format:	Book
Published:	MDPI AG, 2022-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Real-world trough concentrations and effectiveness of long-acting cabotegravir and rilpivirine: a multicenter prospective observational study in SwitzerlandResearch in context
by: Paul Thoueille, et al.
Published: (2024)

Population pharmacokinetics of rilpivirine following oral administration and long-acting intramuscular injection in real-world people with HIV
by: Paul Thoueille, et al.
Published: (2024)

Experiences to date with the logistical management of long-acting cabotegravir and rilpivirine
by: Kamile Johnson, et al.
Published: (2022)

Method development and validation for Cabotegravir and Rilpivirine by using HPLC and its degradants are characterized by LCMS and FTIR
by: Anuradha Vejendla, et al.
Published: (2021)

Development and Validation of Stability Indicating RP-HPLC Method for the Simultaneous Determination of Cabotegravir and Rilpivirine in Bulk and Injection Dosage Form
by: A Suneetha, et al.
Published: (2022)

The role of rilpivirine in Southern Africa
by: Michelle A. Moorhouse, et al.
Published: (2019)

Physiologically Based Pharmacokinetic Modelling of Cabotegravir Microarray Patches in Rats and Humans
by: Hannah Kinvig, et al.
Published: (2023)

Sultiame pharmacokinetic profile in plasma and erythrocytes after single oral doses: A pilot study in healthy volunteers
by: Kim Dao, et al.
Published: (2020)

Emtricitabine/rilpivirine/tenofovir disoproxil fumarate for the treatment of HIV-1 infection in adults
by: Wissam K. Kabbara, et al.
Published: (2015)

Evaluation of drug-drug interaction between rilpivirine and rifapentine using PBPK modelling
by: Sandra Grañana-Castillo, et al.
Published: (2022)

A Pharmacokinetic Dose-Optimization Study of Cabotegravir and Bictegravir in a Mouse Pregnancy Model
by: Haneesha Mohan, et al.
Published: (2022)

The Effect of Moderate- and High-Fat Meals on the Bioavailability of Dolutegravir/Rilpivirine Fixed-Dose Combination Tablet
by: Mehta R, et al.
Published: (2020)

Rilpivirine inhibits SARS-CoV-2 protein targets: A potential multi-target drug
by: Fuad Ameen, et al.
Published: (2021)

Development and Validation of RP-HPLC Method for the Estimation of Dolutegravir and Rilpivirine in Bulk and its Tablet Dosage form
by: P Pravalika, et al.
Published: (2021)

Efficacy of switching to dolutegravir plus rilpivirine, the small-tablet regimen, in patients with dysphagia: two case reports
by: Takefumi Suzuki, et al.
Published: (2017)

Long-Acting Injectable Cabotegravir for HIV Preexposure Prophylaxis Among Sexual and Gender Minorities: Protocol for an Implementation Study
by: Beatriz Grinsztejn, et al.
Published: (2023)

Design and synthesis of cabotegravir derivatives bearing 1,2,3-triazole and evaluation of anti-liver cancer activity
by: Huaxia Xie, et al.
Published: (2023)

Dose-Ranging Plasma and Genital Tissue Pharmacokinetics and Biodegradation of Ultra-Long-Acting Cabotegravir In Situ Forming Implant
by: Isabella C. Young, et al.
Published: (2023)

Development of a physiologically‐based pharmacokinetic model to simulate the pharmacokinetics of intramuscular antiretroviral drugs
by: Sara Bettonte, et al.
Published: (2024)

Population Pharmacokinetics in Oncology and Its Clinical Applications
by: Nicolas Widmer, et al.
Published: (2024)

Strategies to reduce the wearing time of cabotegravir sodium dissolving microarray pacthes by facilitating fast tip detachment from the baseplate
by: Fabiana Volpe-Zanutto, et al.
Published: (2022)

The Steps to Therapeutic Drug Monitoring: A Structured Approach Illustrated With Imatinib
by: Thierry Buclin, et al.
Published: (2020)

Precision Oncology by Point-of-Care Therapeutic Drug Monitoring and Dosage Adjustment of Conventional Cytotoxic Chemotherapies: A Perspective
by: Myriam Briki, et al.
Published: (2023)

Willingness to pay and price elasticity of demand for long-acting injectable cabotegravir among men who have sex with men in Guangxi, China
by: Shiwen Chen, et al.
Published: (2024)

Synthesis and biological evaluation of novel 1,2,3-triazole hybrids of cabotegravir: identification of potent antitumor activity against lung cancer
by: Yajie Guo, et al.
Published: (2023)

Everything counts - a method to determine viral suppression among people living with HIV using longitudinal data for the HIV care continuum - results of two large, German, multi-center real-life cohort studies over 20 years (1999-2018)
by: Daniel Schmidt, et al.
Published: (2021)

Cause of death coding in Switzerland: evaluation based on a nationwide individual linkage of mortality and hospital in-patient records
by: Ueli Zellweger, et al.
Published: (2019)

Preparing for the Implementation of Long-Acting Injectable Cabotegravir for HIV Pre-Exposure Prophylaxis Within the Brazilian Public Health System (ImPrEP CAB Brasil): Qualitative Study
by: M Cristina Pimenta, et al.
Published: (2024)

Combined <i>In Silico</i> and <i>In Vitro</i> Evidence Supporting an Aurora A Kinase Inhibitory Role of the Anti-Viral Drug Rilpivirine and an Anti-Proliferative Influence on Cancer Cells
by: Saiful Islam, et al.
Published: (2022)

Model‐based meta‐analysis of salbutamol pharmacokinetics and practical implications for doping control
by: Perrine Courlet, et al.
Published: (2022)

From Personalized to Precision Medicine in Oncology: A Model-Based Dosing Approach to Optimize Achievement of Imatinib Target Exposure
by: Sylvain Goutelle, et al.
Published: (2023)

Medical Aid in Dying: Europe's Urgent Medico-Ethical Challenge
by: Uwe Güth, et al.
Published: (2023)

La reconnaissance
by: Alain Battegay
Published: (2008)

Implementation and Cross-Validation of a Pharmacokinetic Model for Precision Dosing of Busulfan in Hematopoietic Stem Cell Transplanted Children
by: Sylvain Goutelle, et al.
Published: (2022)

Awareness and management of elevated blood pressure among human immunodeficiency virus-infected adults receiving antiretroviral therapy in urban Zambia: a call to action
by: Sophie Bauer, et al.
Published: (2017)

Occupational exposure to benzene and mortality risk of lymphohaematopoietic cancers in the Swiss National Cohort
by: Calvin Ge, et al.
Published: (2024)

COVID-19 and HIV testing: different viruses but similar prejudices and psychosocial impacts
by: Janet Michel, et al.
Published: (2021)

Social participation in inclusive physical education: On the importance of class, teaching methods and teacher characteristics
by: Vitus Furrer
Published: (2023)

Prescribing issues in older adults living with HIV: thinking beyond drug-drug interactions with antiretroviral drugs
by: Françoise Livio, et al.
Published: (2019)

Ensuring Sufficient Trough Plasma Concentrations for Broad-Spectrum Beta-Lactam Antibiotics in Children With Malignancies: Beware of Augmented Renal Clearance!
by: Pascal André, et al.
Published: (2022)